2018 American Transplant Congress
Urinary Tract Infections after Renal Transplantation: Is Male Gender a Risk Factor for Resistant Microorganisms?
Nephrology, Marmara University, School of Medicine, Istanbul, Turkey.
Introduction: Renal transplantation is the most effective treatment method for patients with the end-stage renal disease. The most common infections among these patients are urinary…2018 American Transplant Congress
Natural History and Determinants of Infectious Complications after Kidney Transplantation: A Nationwide Prospective Population Based Cohort
Paris Transplant Group, Paris, France.
Background: Although Infectious complications are a major cause of morbidity and mortality in KTR, little is known about their natural history and determinants at a…2018 American Transplant Congress
Long-Term Outcome of Kidney Transplant Recipient with HTLV-1 Infection
BackgroundThe human T-lymphotropic virus (HTLV-I), which is endemic in southern Japan, is recognized as the cause of adult T cell leukemia-lymphoma (ATL) and HTLV-1-associated myelopathy…2018 American Transplant Congress
Efficacy and Safety of Acute Antibody Rejection Treatment in Pediatric Kidney Transplant Recipients
Purpose: Evaluate the efficacy and safety of acute antibody mediated rejection (AMR) treatment modalities in pediatric kidney transplant recipients (KTR).Methods: A single-center retrospective chart review…2018 American Transplant Congress
CMV-Specific CD8+ T-Cell Immune Competence Score as Predictor of Outcome for CMV Infection after Transplantation
Introduction: Control of cytomegalovirus (CMV) infection after solid organ transplantation (SOT) requires a functional immune system. We assessed the utility of a flow cytometric assay…2018 American Transplant Congress
How Safe is Immunosuppression Maintenance 1 Year after Renal Allograft Failure?
University of Florida, Gainesville.
In 2013, our center opened a specialty clinic to maintain immunosuppression (IS) after renal graft failure in an attempt to minimize further sensitization in retransplant…2018 American Transplant Congress
Building a Third-Party VST Bank from Scratch- The Cincinnati Experience
BackgroundViral infections remain a challenge to treat and significantly contribute to morbidity and mortality. Virus specific T cells (VSTs) have shown clinical efficacy, with minimal…2018 American Transplant Congress
Polyclonal Cellular Immune Function is Dose-Dependently Inhibited by Immunosuppressive Drugs but Has Limited Value in Predicting Infection or Rejection Episodes
1Saarland University, Homburg/Saar, Germany; 2Saarland University, Homburg/Saar, Germany.
Background: Dosage of immunosuppressive drugs in transplant patients must be balanced to prevent graft rejection and infectious complications. Knowledge on general immune function may therefore…2018 American Transplant Congress
Clinical Outcomes of Patients with BK Viremia in ABO-Incompatible Kidney Transplantation and Comparison with ABO-Compatible Kidney Transplantation
Internal Medicine, Asan Medical Center, Seoul, Republic of Korea.
Background and Aim:ABO-incompatible kidney transplantation (ABOiKT) recipients may have an increased risk of BK virus allograft nephropathy (BKVAN), a major cause of renal dysfunction and…2018 American Transplant Congress
Gut Microbiota Dysbiosis is an Independent Risk Factor for Development of Urinary Tract Infections in Kidney Transplantation
1Weill Cornell, NY, NY; 2Memorial Sloan Kettering, NY, NY.
INTRODUCTION. We examine the relationship between the gut microbiota and development of Escherichia and Enterococcus urinary tract infections (UTIs).METHODS. We recruited 170 kidney transplant recipients…
- « Previous Page
- 1
- …
- 57
- 58
- 59
- 60
- 61
- …
- 84
- Next Page »